Compare SHC & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHC | NVST |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.1B |
| IPO Year | 2020 | 2019 |
| Metric | SHC | NVST |
|---|---|---|
| Price | $15.55 | $24.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $20.33 | ★ $26.46 |
| AVG Volume (30 Days) | 2.7M | ★ 2.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 68.75 | ★ 104.31 |
| EPS | 0.09 | ★ 0.23 |
| Revenue | $1,163,617,000.00 | ★ $2,566,500,000.00 |
| Revenue This Year | $7.51 | $6.67 |
| Revenue Next Year | $6.00 | $3.55 |
| P/E Ratio | $171.72 | ★ $104.80 |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $10.80 | $16.41 |
| 52 Week High | $19.85 | $30.42 |
| Indicator | SHC | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 36.73 |
| Support Level | $15.18 | $24.21 |
| Resistance Level | $16.55 | $25.41 |
| Average True Range (ATR) | 0.46 | 1.17 |
| MACD | -0.04 | -0.29 |
| Stochastic Oscillator | 66.75 | 8.47 |
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.